Dermatomyositis associated with malignant melanoma - A marker of poor prognosis?

Journal of the American Academy of Dermatology

Volumn 54, Issue 2, 2006, Pages 221-226

  Schiller, Meinhard ^a   Böhm, Markus ^a   Hensen, Peter ^a   Riemann, Helge ^b   Luger, Thomas A ^a   Nashan, Dorothée ^c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE DURATION; HUMAN; LYMPH NODE METASTASIS; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

ADULT; COMORBIDITY; DERMATOMYOSITIS; DISEASE PROGRESSION; HUMANS; MELANOMA; PROGNOSIS; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 31344447210     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.10.026     Document Type: Article

References (48)

1. M. Böhm, M. Schiller, D. Nashan, R. Stadler, T.A. Luger, and D. Metze Diffuse melanosis arising from metastatic melanoma: pathogenetic function of elevated melanocyte peptide growth factors J Am Acad Dermatol 44 2001 747 754
2. J.J. Nordlund, J.M. Kirkwood, B.M. Forget, G. Milton, D.M. Albert, and A.B. Lerner Vitiligo in patients with metastatic melanoma: a good prognostic sign J Am Acad Dermatol 9 1983 689 696
3. R.F. Wagner Jr., and L. Nathanson Paraneoplastic syndromes, tumor markers, and other unusual features of malignant melanoma J Am Acad Dermatol 14 1986 249 256
4. P. Duhra, and A. Ilchyshyn Prolonged survival in metastatic malignant melanoma associated with vitiligo Clin Exp Dermatol 16 1991 303 305
5. V. Cavallari, S.P. Cannavo, A.F. Ussia, G. Moretti, and A. Albanese Vitiligo associated with metastatic malignant melanoma Int J Dermatol 35 1996 738 740
6. C.M. Balch, A.C. Buzaid, S.J. Soong, M.B. Atkins, N. Cascinelli, and D.G. Coit Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 2001 3635 3648
7. B.M. Czarnetzki, E. Macher, S. Suciu, D. Thomas, P.A. Steerenberg, and P. Rumke Long-term adjuvant immunotherapy in stage I high-risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC Protocol 18781) Eur J Cancer 29A 1993 1237 1242
8. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 1975 344 347
9. F.D. Arundell, R.D. Wilkinson, and J.R. Haserick Dermatomyositis and malignant neoplasms in adults. A survey of twenty years' experience Arch Dermatol 82 1960 772 775
10. A.R. Amoretti, F. Burgoa, P. Ravecca, and R. Vignale Melanoma en leucoderma y dermatomyositis An Fac Med Univ Repub Montev Urug 46 1961 77 81
11. J. Cabre Dermatomyosite aigné au cours de l'evolution d'un mélanome malin généralisé Bull Soc Fr Dermatol Syphiligr 68 1961 846 849
12. W. Gertler Dermatomyositis bei metastasierendem Melanom Dermatol Wochenschr 143 1961 442 443
13. A. Katz, and J.W. Digby Malignant melanoma and dermatomyositis Can Med Assoc J 93 1965 1367 1369
14. A. Leoni, and R. Cogo Dermatomiosite preceduta da melanoma maligno Minerva Dermatol 42 1967 161 164
15. T.D. Sunnenberg, and C.S. Kitchens Dermatomyositis associated with malignant melanoma. Parallel occurrence, remission, and relapse of the two processes in a patient Cancer 51 1983 2157 2158
16. P. Belaube, M. Pizzi, J.F. Pelissier, J.L. Gastaut, and Y. Privat Dermatomyosite aigue au cours de l'evolution d'un naevocarcinome du gros orteil Sem Hop 59 1983 192 194
17. D.I. Golovchenko, and A.E. Fedorenko Dermatomiozit u bol'nogo s melanomoi stopy Vestn Dermatol Venerol 12 1984 50 52
18. L. Gruberg, P. Langevitz, D. Levartowsky, and M. Pras Dermatomyositis in a patient with malignant melanoma Clin Exp Rheumatol 12 1994 321 323
19. G. Sais, J. Marcoval, A. Juggla, N. Curco, and O. Servitje Dermatomyositis and metastatic malignant melanoma, with complete regression of the primary lesion Br J Dermatol 130 1994 796 797
20. L. Scerri, I. Zaki, B.R. Allen, and P. Golding Dermatomyositis associated with malignant melanoma - case report and review of the literature Clin Exp Dermatol 19 1994 523 525
21. C. Lersch, R. Fuchs, H. Frank, and W. Schepp Dermatomyositis als Komplikation eines metastasierten Melanoms - Fallbeschreibung und Literaturübersicht Immun Infekt 23 1995 23 24
22. A.F. Shorr, M. Yacavone, S. Seguin, L.W. Jackson, and G.J. Dennis Dermatomyositis and malignant melanoma Am J Med Sci 313 1997 249 251
23. C.R. Maoz, P. Langevitz, A. Livneh, Z. Blumstein, M. Sadeh, and I. Bank High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis Semin Arthritis Rheum 27 1998 319 324
24. L.L. Dietrich, A.J. Bridges, and M.R. Albertini Dermatomyositis after interferon alpha treatment Med Oncol 17 2000 64 69
25. M. Marschalko, G. Ponyai, E. Ablonczy, and A. Horvath Dermatomyositis: clinical study of 34 patients Orv Hetil 141 2000 225 229
26. G. Quéreux, S. Lachaise, A. Khammari, and B. Dréno Dermatomyosite associée à l'interféron α chez une patient suivie pout mélanome Ann Dermatol Venereol 128 Suppl 2001 S203 S204
27. M. Burnouf, E. Mahe, P. Verpillat, V. Descamps, B. Lebrun-Vignes, and C. Picard-Dahan Les necroses cutanees dans les dermatomyosites de l'adulte sont predictives de l'association a une neoplasie Ann Dermatol Venereol 130 2003 313 316
28. C. Michot, O. Dereure, J.F. Baurain, V. Brichard, and B. Guillot Dermatomyositis occurring during treatment of a patient with metastatic melanoma Melanoma Res 14 2004 435 436
29. B.E. Barnes, and B. Mawr Dermatomyositis and malignancy. A review of the literature Ann Intern Med 84 1976 68 76
30. J.P. Callen, J.F. Hyla, G.G. Bole Jr., and D.R. Kay The relationship of dermatomyositis and polymyositis to internal malignancy Arch Dermatol 116 1980 295 298
31. P. Bernard, and J.M. Bonnetblanc Dermatomyositis and malignancy J Invest Dermatol 100 Suppl 1993 128S 132S
32. A. Airio, E. Pukkala, and H. Isomaki Elevated cancer incidence in patients with dermatomyositis: a population based study J Rheumatol 22 1995 1300 1303
33. W.H. Chow, G. Gridley, L. Mellemkjaer, J.K. McLaughlin, J.H. Olsen, and J.F. Fraumeni Jr. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark Cancer Causes Control 6 1995 9 13
34. N. Basset-Seguin, J.C. Roujeau, R. Gherardi, J.C. Guillaume, J. Revuz, and R. Touraine Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases Arch Dermatol 126 1990 633 637
35. J.M. Bonnetblanc, P. Bernard, and J. Fayol Dermatomyositis and malignancy. A multicenter cooperative study Dermatologica 180 1990 212 216
36. N.H. Cox, C.M. Lawrence, J.A. Langtry, and F.A. Ive Dermatomyositis. Disease associations and an evaluation of screening investigations for malignancy Arch Dermatol 126 1990 61 65
37. C.L. Hill, Y. Zhang, B. Sigurgeirsson, E. Pukkala, L. Mellemkjaer, and A. Airio Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study Lancet 357 2001 96 100
38. B. Sigurgeirsson Skin disease and malignancy. An epidemiological study Acta Derm Venereol Suppl (Stockh) 178 1992 1 110
39. A.G. Duncan, J.B. Richardson, J.B. Klein, I.N. Targoff, T.M. Woodcock, and J.P. Callen Clinical, serologic, and immunogenetic studies in patients with dermatomyositis Acta Derm Venereol 71 1991 312 316
40. A. Mebazaa, H. Boussen, R. Nouira, L. Rokbani, A. Osman-Dhahri, and N. Bouaouina Dermatomyositis and malignancy in Tunisia: a multicenter national retrospective study of 20 cases J Am Acad Dermatol 48 2003 530 534
41. N. Wakata, T. Kurihara, E. Saito, and M. Kinoshita Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study Int J Dermatol 41 2002 729 734
42. Y.J. Chen, C.Y. Wu, and J.L. Shen Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study Br J Dermatol 144 2001 825 831
43. E. Mahe, V. Descamps, M. Burnouf, and B. Crickx A helpful clinical sign predictive of cancer in adult dermatomyositis: cutaneous necrosis Arch Dermatol 139 2003 539
44. V. Gallais, B. Crickx, and S. Belaich Facteurs pronostiques et signes predictifs de cancer au cours de la dermatomyosite de l'adulte Ann Dermatol Venereol 123 1996 722 726
45. P.G. Buettner, U. Leiter, T.K. Eigentler, and C. Garbe Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society Cancer 103 2005 616 624
46. H.I. Hall, D.R. Miller, J.D. Rogers, and B. Bewerse Update on the incidence and mortality from melanoma in the United States J Am Acad Dermatol 40 1999 35 42
47. E. de Vries, F.I. Bray, J.W. Coebergh, and D.M. Parkin Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia Int J Cancer 107 2003 119 126
48. K. Boeck, S. Hofmann, M. Klopfer, U. Ian, T. Schmidt, and R. Engst Melanoma-associated paraneoplastic retinopathy: case report and review of the literature Br J Dermatol 137 1997 457 460